SF 4058
Status in the Senate - 93rd Legislature (2023 - 2024)
Revisor number: 24-06362
Description
Commissioner of human services authorization to provide separate reimbursement for biological products provided in the inpatient hospital setting as part of cell or gene therapy to treat rare diseases
Authors
Actions
Senate
| 02/22/2024 | |
| 02/22/2024 |
Referred to
Health and Human Services
|
|
See
HF5247
|
| Senate Actions | House Actions |
|---|---|
| 02/22/2024 | |
|
Referred to
Health and Human Services
|
|
| Final Actions | |
|
See
HF5247
|
|